Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Shares withheld for taxes Director gave up 32,904 shares (to pay taxes)
  2. 4 Exercise or conversion Director acquired 42,897 shares (option exercise)
  3. 4 Other acquisition Chief Scientific Officer acquired 650 shares (other)
  4. 4 Other acquisition Cheif Fianancial Officer acquired 2,604 shares (other)
  5. 4 Other acquisition Chief Operating Officer acquired 6,507 shares (other)
  6. 5 Insider Annual Insider Trading Report
  7. 3 Insider Initial Statement of Ownership
  8. 4 Exercise or conversion CEO, Chairman of the Board acquired 3,533 shares (option exercise)
  9. 4 Other acquisition Chief Operating Officer acquired 2,108 shares (other)
  10. 4 Other acquisition Chief Fiancial Officer acquired 596 shares (other)
  11. 4 Grant or award CEO, Chairman of the Board acquired 147,100 shares (grant or award)
  12. 4 Grant or award Chief Operating Officer acquired 55,162 shares (grant or award)
  13. 4 Grant or award Chief Scientific Officer acquired 11,032 shares (grant or award)
  14. 4 Grant or award Chief Fnancial Officer acquired 11,032 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 12 of 30 · 591 filings